抗栓药物与早期胃癌内镜黏膜下剥离术后迟发性出血的关联性研究
康维娜 , 甄翠娜 , 冯晓沙 , 李学永
中国现代医学杂志 ›› 2026, Vol. 36 ›› Issue (17) : 69 -74.
抗栓药物与早期胃癌内镜黏膜下剥离术后迟发性出血的关联性研究
Association between antithrombotic drugs and delayed bleeding after endoscopic submucosal dissection for early gastric cancer
目的 分析抗栓药物与早期胃癌内镜黏膜下剥离术(ESD)术后迟发性出血的关联性。 方法 选取2023年1月—2026年1月在邯郸市第一医院接受ESD治疗的早期胃癌患者99例,根据术后是否发生迟发性出血分为迟发性出血组(12例)和未出血组(87例)。比较两组临床资料,并采用多因素逐步Logistic回归分析早期胃癌ESD术后迟发性出血的影响因素。 结果 迟发性出血组与未出血组性别构成、年龄、合并糖尿病率、合并高血压率、合并心血管疾病率、病理类型构成、抗栓药物单药使用率、单独血小板使用率、单独抗凝药使用率、多种抗血小板药物使用率、抗血小板和抗凝药使用率、单独抗血小板药物使用率、单独抗凝药使用率、抗血小板和抗凝药使用率比较,差异均无统计学意义(P >0.05)。迟发性出血组浸润深度为黏膜下层占比、抗血小板药物使用率、抗栓药物多药使用率、多种抗血小板药物使用率均高于未出血组(P <0.05)。多因素逐步Logistic回归分析结果显示,浸润深度为黏膜下层[O^R =7.150(95% CI:1.562,32.732)]、抗血小板药物使用[O^R =6.340(95% CI:1.366,29.417)]、抗凝药物使用[O^R =8.947(95% CI:1.148,69.714)]、抗栓药物使用多药[O^R =11.003(95% CI:1.290,93.883)]均是早期胃癌ESD术后迟发性出血的危险因素(P <0.05)。 结论 抗血小板药物、抗凝药及抗栓药物多药联合使用均是早期胃癌ESD术后迟发性出血的独立危险因素,且风险会随药物种类增加而升高;浸润深度达黏膜下层亦显著增加迟发性出血的风险。
Objective To analyze the association between antithrombotic drugs and delayed bleeding after endoscopic submucosal dissection (ESD) for early gastric cancer. Methods Clinical data of 99 patients with early gastric cancer who underwent ESD in our hospital from January 2023 to January 2026 were collected. Patients were categorized into a delayed bleeding group (n = 12) and a non-bleeding group (n = 87) based on the occurrence of postoperative delayed bleeding. Clinical characteristics were compared between the two groups, and multivariate logistic regression analysis was performed to identify risk factors for delayed bleeding after ESD. Results There were no statistically significant differences between the delayed bleeding group and the non-bleeding group in terms of sex distribution, age, prevalence of diabetes mellitus, prevalence of hypertension, prevalence of cardiovascular disease, pathological type composition, single antithrombotic drug use rate, single antiplatelet drug use rate, single anticoagulant use rate, multiple antiplatelet drug use rate, combined antiplatelet and anticoagulant use rate, single antiplatelet drug use rate alone, single anticoagulant use rate alone, and combined antiplatelet and anticoagulant use rate (P > 0.05). Statistically significant differences were observed between the two groups in invasion depth, antiplatelet drug use rate, anticoagulant use rate, multiple antithrombotic drug use rate, and multiple antiplatelet drug use rate (P < 0.05). The delayed bleeding group had a higher proportion of submucosal invasion, a higher antiplatelet drug use rate, a higher multiple antithrombotic drug use rate, and a higher multiple antiplatelet drug use rate than the non-bleeding group. Multivariate analysis showed that submucosal invasion [O^R = 7.150 (95% CI: 1.562, 32.732) ], antiplatelet drug use [O^R = 6.340 (95% CI: 1.366, 29.417) ], anticoagulant drug use [O^R = 8.947 (95% CI: 1.148, 69.714) ], and use of multiple antithrombotic drugs [O^R = 11.003 (95% CI: 1.290, 93.883) ] were independent risk factors for delayed bleeding after ESD for early gastric cancer (P < 0.05). Conclusion The use of antiplatelet drugs, anticoagulants, and multiple antithrombotic drugs is independent risk factors for delayed bleeding after ESD for early gastric cancer, with risk increasing with the number of drug types. Submucosal invasion also significantly increases the risk of delayed bleeding.
| [1] |
王裕新, 潘凯枫, 李文庆. 2022全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2024, 10(3): 1-16. |
| [2] |
付莉莉, 赵金龙, 张静, 艾司氯胺酮麻醉诱导与维持对老年胃癌手术患者血流动力学和脑氧代谢的影响[J]. 中国现代医学杂志, 2026, 36(5): 76-82. |
| [3] |
曹一鑫, 李峄清, 殷润婷. 胃癌组织中PRMT5的表达与临床病理特征和预后的关系[J]. 中国现代医学杂志, 2023, 33(6): 14-19. |
| [4] |
王卫卫, 邢文韬, 张爱青, 血管内皮生长因子、程序性死亡受体-1联合胃功能三项对早期胃癌的诊断及预后评估价值[J]. 陕西医学杂志, 2024, 53(12): 1663-1667. |
| [5] |
刘博文, 殷云勤, 高宇辉. 早期胃癌分化程度与临床特征的关系研究[J]. 中国现代医学杂志, 2023, 33(19): 16-23. |
| [6] |
王海涛, 沈颖洲, 程正源, 内镜黏膜下剥离术和外科手术治疗早期胃癌的疗效评价[J]. 中国现代医学杂志, 2026, 36(1): 97-102. |
| [7] |
张文慧, 王红霞, 严丽洁. ESD治疗老年早期胃癌患者术后迟发性出血的预测模型的建立及预防策略研究[J]. 河北医科大学学报, 2025, 46(7): 756-761. |
| [8] |
ZHU H, LI F D, TAO K, et al. Bleeding after endoscopic resection between direct oral anticoagulants or warfarin: systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2021, 36(9): 2363-2374. |
| [9] |
VEITCH A M, RADAELLI F, ALIKHAN R, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update[J]. Endoscopy, 2021, 53(9): 947-969. |
| [10] |
ASGE Standards of Practice Committee, ACOSTA R D, ABRAHAM N S, et al. The management of antithrombotic agents for patients undergoing GI endoscopy[J]. Gastrointest Endosc, 2016, 83(1): 3-16. |
| [11] |
FURUHATA T, KAISE M, HOTEYA S, et al. Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy[J]. Gastric Cancer, 2017, 20(1): 207-214. |
| [12] |
陈佳园, 陈怡, 陈成帷, 抗栓药物对内镜黏膜下剥离术术后出血的影响[J]. 中国现代医生, 2021, 59(34): 105-108. |
| [13] |
公宇, 张月明, 朱继庆, 内镜黏膜下剥离术治疗早期胃癌及癌前病变发生迟发性出血的相关因素分析[J]. 中华肿瘤杂志, 2021, 43(8): 861-865. |
| [14] |
叶露, 钟继红, 张烁, 云母对早期胃癌内镜黏膜下剥离术术后人工溃疡愈合的有效性研究[J]. 北京中医药大学学报, 2026, 49(1): 24-32. |
| [15] |
高欣, 李璇, 王云, 富马酸伏诺拉生与雷贝拉唑联合黏膜保护剂对内镜黏膜下剥离术后人工溃疡疗效的随机对照研究[J]. 中华消化内镜杂志, 2024, 41(5): 366-371. |
| [16] |
侯慧, 万艳, 朱从艳, 基于机器学习算法建立胃癌术后肠内营养中断的预测模型[J]. 中华全科医学, 2025, 23(12): 2143-2147. |
| [17] |
郭金玲, 张秀宁, 刘路, 内镜黏膜下剥离术后早期胃癌患者迟发性出血的危险因素及其预测价值研究[J]. 中国内镜杂志, 2025, 31(9): 62-68. |
| [18] |
CAI R S, YANG W Z, CUI G R. Associate factors for endoscopic submucosal dissection operation time and postoperative delayed hemorrhage of early gastric cancer[J]. World J Gastrointest Surg, 2023, 15(1): 94-104. |
| [19] |
贾儒渊, 樊志惠, 王朝凤, 抗栓治疗的早期胃癌患者内镜黏膜下剥离术后出血的影响因素分析[J]. 中国医药, 2025, 20(1): 80-84. |
| [20] |
WANG J X, WU S S, XING J, et al. External validation of the BEST-J score and a new risk prediction model for ESD delayed bleeding in patients with early gastric cancer[J]. BMC Gastroenterol, 2022, 22(1): 194. |
| [21] |
HASHIMOTO M, HATTA W, TSUJI Y, et al. Rebleeding in patients with delayed bleeding after endoscopic submucosal dissection for early gastric cancer[J]. Dig Endosc, 2021, 33(7): 1120-1130. |
| [22] |
范磊, 郭忠武, 王斌. 早期胃癌患者内镜黏膜下剥离术后迟发性出血的发生率及影响因素:一项单中心观察性研究[J]. 肿瘤预防与治疗, 2025, 38(3): 210-215. |
| [23] |
康佳璇, 金世柱, 张波. 早期胃癌ESD术后迟发性出血相关危险因素研究进展[J]. 胃肠病学和肝病学杂志, 2026, 35(3): 423-426. |
| [24] |
TOMIDA H, YOSHIO T, IGARASHI K, et al. Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study[J]. Gastric Cancer, 2021, 24(1): 179-189. |
| [25] |
陈静, 朱贞祥, 徐绍莲, 早期胃癌内镜黏膜下剥离术后迟发性出血风险现状及其影响因素分析[J]. 中华保健医学杂志, 2023, 25(1): 79-82. |
| [26] |
FUJIMOTO K, FUJISHIRO M, KATO M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment[J]. Dig Endosc, 2014, 26(1): 1-14. |
2025年度河北省医学科学研究课题计划(20251288)
/
| 〈 |
|
〉 |